WallStreetZenWallStreetZen

NASDAQ: GALT
Galectin Therapeutics Inc Stock Ownership - Who owns Galectin Therapeutics?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Galectin Therapeutics Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Kary EldredDirector2025-07-211,000$2.93
$2.93kBuy
Kevin D. FreemanDirector2025-07-175,000$2.90
$14.50kBuy
James C. Czirr10% Owner2025-06-0670,000$2.11
$147.70kBuy
James C. Czirr10% Owner2025-06-0640,000$1.98
$79.20kBuy
James C. Czirr10% Owner2025-06-0631,250$0.89
$27.81kBuy
James C. Czirr10% Owner2025-06-0646,875$2.39
$112.03kBuy
James C. Czirr10% Owner2025-06-0640,000$1.11
$44.40kBuy
James C. Czirr10% Owner2025-06-0640,000$2.11
$84.40kBuy
James C. Czirr10% Owner2025-06-0625,000$4.72
$118.00kBuy
James C. Czirr10% Owner2025-06-0630,000$2.86
$85.80kBuy

1 of 3

GALT insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when GALT insiders and whales buy or sell their stock.

GALT Shareholders

What type of owners hold Galectin Therapeutics Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
10x Fund LP40.20%25,751,845$99.92MInsider
James C. Czirr32.81%21,015,907$81.54MInsider
Rod D. Martin18.82%12,057,197$46.78MInsider
Richard E. Uihlein16.12%10,328,981$40.08MInsider
David Platt13.14%8,418,743$32.66MInsider
Vanguard Group Inc3.41%2,184,548$8.48MInstitution
Osaic Holdings Inc1.86%1,190,535$4.62MInstitution
Blackrock Inc1.39%891,879$3.46MInstitution
Joel Lewis1.31%836,592$3.25MInsider
Jane Street Group LLC1.17%748,652$2.90MInstitution

1 of 3

GALT vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
GALT11.56%88.44%Net BuyingNet Buying
NMRA26.18%73.82%Net Selling
TVRD5.93%94.07%Net Selling
ALLO70.14%29.86%Net SellingNet Selling
LXEO78.27%13.18%Net BuyingNet Selling
View Top Biotech Stocks

Galectin Therapeutics Stock Ownership FAQ

Who owns Galectin Therapeutics?

Galectin Therapeutics (NASDAQ: GALT) is owned by 16.22% institutional shareholders, 124.06% Galectin Therapeutics insiders, and 0.00% retail investors. 10x Fund LP is the largest individual Galectin Therapeutics shareholder, owning 25.75M shares representing 40.20% of the company. 10x Fund LP's Galectin Therapeutics shares are currently valued at $105.58M.

If you're new to stock investing, here's how to buy Galectin Therapeutics stock.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.